Introduced in North America through its Florastor® brand, Biocodex is a French family-owned pharmaceutical company that has grown from a pioneer to a major international player in the microbiota realm.
Since 1953, the company has been developing and marketing the world's first probiotic yeast strain, Saccharomyces boulardii CNCM I-745.
In order to educate both health professionals and the general public, Biocodex provides, through the web platform "MicrobiotaEvents", the latest research, developments and scientific content in the field of microbiota.
.jpeg?sw=1920&sfrm=png&q=90)
.jpeg?sw=1920&sfrm=png&q=90)
